Alnara Pharmaceuticals Inc Obtains $20,000,000 Series A Round

  • Feed Type
  • Date
    10/30/2008
  • Company Name
    Alnara Pharmaceuticals Inc
  • Mailing Address
    800 Boylston Street Boston, MA 02199
  • Company Description
    Alnara Pharmaceuticals Inc is a pharmaceutical company developing innovative non-systemic protein therapeutics for the treatment of metabolic and inflammatory diseases.
  • Website
    http://www.alnara.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $20,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds from the financing will be used to accelerate the development of non-systemic protein therapeutics.
  • M&A Terms
  • Venture Investor
    Frazier Healthcare Ventures
  • Venture Investor
    Third Rock Ventures
  • Venture Investor
    Bessemer Venture Partners

By posting a comment, you agree to our terms and conditions.